Xvivo Perfusion
Clinical trials sponsored by Xvivo Perfusion, explained in plain language.
-
New machine could save more hearts for transplant
Disease control OngoingThis study tests a method to preserve hearts from donors after circulatory death using a machine that keeps them cool and oxygenated. The goal is to increase the number of hearts available for transplant. About 20 adults with heart failure who are already on the transplant list w…
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated May 17, 2026 02:55 UTC
-
New heart preservation method could save more lives in transplants
Disease control OngoingThis study compares a new method of keeping donor hearts healthy during transport (non-ischemic preservation) to the standard cold storage method. The goal is to see if the new approach reduces complications and improves survival in the first 30 days and one year after a heart tr…
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New heart preservation method could save more lives in transplants
Disease control OngoingThis study tests a new device that keeps donated hearts healthy without stopping blood flow during transport. It involves 141 adults getting a heart transplant from extended-criteria donors. The goal is to see if this method helps more patients survive one year after transplant.
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New registry tracks Long-Term success of EVLP-Treated donor lungs
Knowledge-focused OngoingThis study collects information from people who receive donor lungs that were treated with a special machine called EVLP (ex vivo lung perfusion) before transplant. The goal is to see how well the lungs work over time and to monitor any serious side effects related to the device.…
Sponsor: XVIVO Perfusion • Aim: Knowledge-focused
Last updated May 17, 2026 02:44 UTC